These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6802107)

  • 21. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effects of glibenclamide and insulin on plasma high density lipoproteins in diabetics (author's transl)].
    Tamai T
    Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):57-77. PubMed ID: 6766887
    [No Abstract]   [Full Text] [Related]  

  • 24. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus.
    Knopp RH; Warth MR; Carrol CJ
    J Reprod Med; 1973 Mar; 10(3):95-101. PubMed ID: 4348501
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
    Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
    Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vanadate on plasma lipoprotein profiles in experimental diabetic rats.
    Sekar N; Govindasamy S
    Biochem Int; 1991 Mar; 23(5):935-40. PubMed ID: 1883401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of the in vitro transfers of esterified cholesterol and triglyceride between human lipoproteins.
    Hopkins GJ; Barter PJ
    Metabolism; 1982 Jan; 31(1):78-81. PubMed ID: 6281610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of the plasma lipoprotein spectrum on the cholesterol level in erythrocyte membranes].
    Torkhovskaia TI; Khalilov EM; Fortinskaia ES; Kliuchnikova ZhI; Ryzhkova LK
    Vopr Med Khim; 1985; 31(4):83-7. PubMed ID: 4049793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
    Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
    Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin and HDL-cholesterol metabolism.
    Fossati P; Romon-Rousseaux M
    Diabete Metab; 1987 Jul; 13(3 Pt 2):390-4. PubMed ID: 3308570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why does experimental insulin deficiency lead to a decrease in removal of very low density-triglyceride from plasma?
    Verschoor L; Chen YD; Reaven GM
    Horm Metab Res; 1984 Feb; 16(2):88-91. PubMed ID: 6368352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein concentrations in untreated adult onset diabetes mellitus and the relationship of the fasting plasma triglyceride concentration to insulin secretion.
    Ballantyne D; White C; Strevens EA; Lawrie TD; Lorimer AR; Manderson WG; Morgan HG
    Clin Chim Acta; 1977 Jul; 78(2):323-9. PubMed ID: 195754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations.
    Nikkilä EA; Hormila P
    Diabetes; 1978 Nov; 27(11):1078-86. PubMed ID: 214367
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma high density lipoprotein cholesterol in streptozotocin diabetic and non-diabetic mice after prolonged administration of glibenclamide, chlorpropamide and metformin.
    Billingham MS; Hall RA; Simpson S; Bailey CJ
    Diabete Metab; 1981 Dec; 7(4):271-4. PubMed ID: 6800858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
    Kissebah AH; Alfarsi S; Evans DJ; Adams PW
    Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein composition in diabetes mellitus.
    Howard BV; Savage PJ; Bennion LJ; Bennett PH
    Atherosclerosis; 1978 Jun; 30(2):153-62. PubMed ID: 209799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual dyslipoproteinemia in a patient with primary systemic amyloidosis and nephrotic syndrome. Role of excessive cholesterol synthesis.
    Eisenberg S; Oschry Y; Schattner A; Bentwich Z
    Isr J Med Sci; 1984 Mar; 20(3):224-31. PubMed ID: 6724868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.
    Billingham MS; Milles JJ; Bailey CJ; Hall RA
    Metabolism; 1989 Sep; 38(9):850-7. PubMed ID: 2671598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.